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Abstract. Infections with helminths and Plasmodium spp. overlap in their geographical distribution. It has been postu-
lated that helminth infections may influence malarial transmission by altering Plasmodium falciparum gametocytogenesis.
This cross-sectional study assessed the effect of helminth infections on P. falciparum gametocyte carriage and on humoral
immune responses to sexual stage antigens in Gabon. Schistosoma haematobium and filarial infections as well as
P. falciparum asexual forms and gametocyte carriage were determined. The antibody responses measured were to sexual
(Pfs230, Pfs48/45) and asexual P. falciparum antigens (AMA1, MSP1, and GLURP). A total of 287 subjects were
included. The prevalence of microscopically detectable P. falciparum asexual parasites was higher in S. haematobium–
infected subjects in comparison to their uninfected counterparts (47% versus 26%, P = 0.003), but this was not different
when filarial infections were considered. Plasmodium falciparum gametocyte carriage was similar between Schistosoma-
or filaria-infected and uninfected subjects. We observed a significant decrease of Pfs48/45 immunoglobulin G titer in
S. haematobium–infected subjects (P = 0.037), whereas no difference was seen for Pfs230 antibody titer, nor for anti-
bodies to AMA1, MSP1, or GLURP. Our findings suggest an effect of S. haematobium on antibody responses to some
P. falciparum gametocyte antigens that may have consequences for transmission-blocking immunity.
INTRODUCTION
In many malaria-endemic regions, helminth infections are
also prevalent, thereby affecting the same population.1,2
There is some evidence suggesting an interaction between
helminth and Plasmodium spp.; however, this has not been
consistent. For example, the prevalence and severity of
malaria as well as Plasmodium falciparum parasitemia density
has been reported to be higher3,4 in some but lower5,6 in other
studies comparing helminth-infected subjects with those
uninfected. Similarly, at the immunological level, there are
conflicting reports regarding the effect of chronic helminth
infections on the immune responses to Plasmodium spp.7,8
The immunological protection against clinical malarial epi-
sodes is associated with a more pronounced Th1 response9
and with the production of cytophilic antibodies (immuno-
globulin G [IgG]1 and IgG3).10,11 However, the immune phe-
notype of helminth-infected subjects is generally characterized
by a Th2 skewed response12,13 and is marked by the produc-
tion of noncytophilic IgG (IgG4) and immunoglobulin E anti-
bodies.14 Helminth infections have also been shown to induce
a strong regulatory network that can dampen the immune
response to unrelated antigens like those from Plasmodium
spp. parasites.15,16 One may, therefore, speculate that malaria-
specific immune responses may be impaired in subjects chron-
ically infected with helminths. However, studies that have
assessed this question have yielded conflicting results indicat-
ing that larger and better designed studies are needed.17–20
To date, studies assessing the coinfection of helminths
and malaria have mainly focused on the asexual forms of
P. falciparum (reviewed in reference 21). However, there are
indications that helminth infections may also influence the prev-
alence or density of P. falciparum gametocytes, the parasite
stage responsible for transmission of infections to mosqui-
toes.22 Studies in Africa and Asia have reported an increased
prevalence of P. falciparum gametocyte carriage in helminth-
infected subjects.22,23 Interestingly using a murine model of
coinfection, Noland and others24 showed that transmission of
gametocytes from mice to mosquitoes was higher when mos-
quitoes were fed on helminth- and malaria-coinfected mice.
Taken together, these findings might indicate a role for hel-
minths in sustaining malarial transmission in coendemic areas.
Toward understanding the effect of helminths on malarial
immunity and transmissibility, we have conducted a cross-
sectional study in an area endemic for both helminths and
malaria. In this study, we have assessed the effect of
Schistosoma haematobium and filarial parasites on the preva-
lence of sexual and asexual forms of P. falciparum parasite.
Finally we determined the association between helminth and
malarial coinfections on the humoral responses to sexual stage
antigens Pfs230 and Pfs48/45, along with a panel of asexual
stage antigens (apical membrane antigen [AMA1], merozoite
surface protein [MSP1], glutamate rich protein [GLURP]).
METHODS
Study population, study area, and study procedure. The
study participants were selected among the population of the
Zilé village in the Moyen-Ogooué Province (Gabon). This vil-
lage is endemic for S. haematobium, Loa loa, and Mansonella
perstans as well as for various geohelminths.25–27 Malaria is
also endemic in the area with P. falciparum reported as dom-
inant species.28 Inclusion of participants in the study was not
random but based on their willingness to participate. Partici-
pants were recruited at home during field visits of the study
team. Urine and blood samples collected in ethylene-
diaminetetraacetic acid tubes were taken for all the subjects
to assess for Schistosoma, filarial, and malarial infection.
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Venous blood was drawn and serum was obtained for
enzyme-linked immunosorbent assay (ELISA).
Parasitological diagnosis. Plasmodium spp. infection was
determined by microscopic examination of thick blood
smears. Asexual forms of the parasite were detected by the
Lambaréné method as described elsewhere.29 The pres-
ence of P. falciparum gametocytes was established using
the World Health Organization method after counting 1,000
leukocytes. DNA extraction and real-time polymerase chain
reaction (PCR) (quantitative PCR) was carried on to detect
submicroscopic infection by asexual stage P. falciparum as
previously described.30
Schistosoma haematobium infection was determined before
inclusion in the study. Schistosoma eggs were sought in 10 mL
of fresh urine passed through a 12-μm pore-size filter.
Absence of infection was set after the negativity of three
urines samples collected after three consecutive days. A sub-
ject was classified as infected if at least one egg was detected
in the urine sample.
Loa loa and M. perstans microfilaria was detected by a
modified Knott method.31 Microfilarial count was determined
by microscopy, and difference between species was established
based on the presence of the sheath of L. loa.
Enzyme-linked immunosorbent assay. Pfs48/45-10C was
obtained from the chimeric R0-10C vaccine protein.32 R0
was cleaved from Pfs48/45-10C, and successful removal of
GLURP-R0 was confirmed by testing plasma samples from
GLURP-vaccinated volunteers.33 Pfs230-230CMB was obtained
from Fraunhofer USA Center for Molecular Biotechnology.
Apical membrane antigen (AMA-1 3D7, Biomedical Primate
Research Center, Rijswijk, The Netherlands), merozoite sur-
face protein 119 (MSP-119 Wellcome allele, provided by Patrick
Corran, London School of Hygiene and Tropical Medicine with
permission of Tony Holder) and R2 region of GLURP, pro-
vided by Michael Theisen, Statens Serum Institut, Copenhagen,
Denmark, were used.
AMA-1, MSP-1, and GLURP ELISAs were performed as
described previously.34 Pfs48/45 and Pfs230 antibodies were
quantified as follows: 96-well Maxisorp NUNC plates (Nalge
Nunc International Corp., Naperville, IL) were coated over-
night at 4°C with 100 μL per well of 0.1 μg/mL of antigen
diluted in phosphate-buffered saline (PBS). Plates were blocked
for 30 minutes with 150 μL of 5% nonfat skim milk (Marvel;
Premier International Foods Ltd., Spalding, United Kingdom)
in PBS. Following this, plates were washed three times with
PBS and 100 μL of test serum was diluted to 1/500 in PBS
(with 1% milk and 0.05% Tween 20) and incubated on the
plates for 4 hours at room temperature. Plates were then
washed three times as before and incubated with 100 μL per
well of human IgG horseradish peroxidase (Pierce Biotechnol-
ogy Inc., Rockford, IL) diluted to 1/40,000 in PBS with 0.05%
Tween 20 for 2 hours at room temperature. Next, plates were
washed four times, then 100 μL of tetramethylbenzidine
substrate solution was added per well, and incubated for
20 minutes. Reactions were stopped using 50 μL per well of
0.2 M sulfuric acid and optical densities (ODs) were measured
at 450 nm (Bio-Rad iMark Microplate Reader; Bio-Rad
Laboratories, Hertfordshire, United Kingdom). For all assays,
averaged sample ODs were normalized (using the midpoint
dilution as reference) against a titration curve fitted to the posi-
tive control sample by least squares minimization using a three-
variable sigmoid model.34,35 The mixture model was used to
distinguish positive and negative samples by fitting test sample
ODs to two Gaussian distributions using maximum likelihood
methods in STATA (Version 11; StataCorp, College Station,
TX). The mean OD of the seronegative (the test samples
with low ODs) population plus three standard deviations was
used as the cutoff value. Antibody densities were expressed as
percentage of the reference value (i.e., the normalized value).
Statistical analysis. The statistical analysis was conducted
using STATA (Version 11, StataCorp) and R (Version 3.0.1;
R core team, Vienna, Austria). Chi-squared test was used for
the comparison of proportion. Continuous data that were not
normally distributed were transformed either using a log10
transformation or a Box–Cox transformation when appropri-
ate. Comparison of mean was carried out using the Student’s
t test or the analysis of variance test for normally distributed
data or the Mann–Whitney and the Kruskal–Wallis test other-
wise. Multivariable linear regression analysis was performed
to assess the relationship between infectious status and the
antibody response specific to P. falciparum gametocyte anti-
gens. Significance level was set for a P value < 0.05.
Ethics. The study was approved by the “Comité d’éthique
Régional Indépendant de Lambaréné”. Informed consent was
obtained from each participant and in case they had less than
18 years old from their parents or legal guardians. Appropri-
ate treatment was given to children found with P. falciparum
or S. haematobium infection as per the local guidelines.
RESULTS
A total of 287 participants were included in this study.
Among them, 229 (81%) had either S. haematobium or one
of the filarial infections, M. perstans or L. loa, whereas 197
(75%) carried P. falciparum parasite as determined by PCR
or 120 (42%) as determined by microscopy. None of the
participants carrying P. falciparum were symptomatic for
malaria. Coinfection with Plasmodium and with one or more
helminth species was found in 155 (55%) subjects (Table 1).
The prevalence of microscopic P. falciparum asexual parasites
was higher in S. haematobium–infected subjects in comparison
to those free of S. haematobium infection (47% versus 26%,
P = 0.003; Table 2), whereas P. falciparum gametocyte carriage
was similar between helminth-infected and helminth-uninfected
TABLE 1
Characteristics of the study population
Characteristics % (n/N)
Age (in years): median (IQR) 11 (8–15)
Sex: M/F 153/134
Hemoglobin level (in g/dL): median (IQR) 11.3 (10.5–12.2)
Subjects with Plasmodium falciparum asexual
stage infection (diagnosed by microscopy)
42 (120/285)
Subjects with P. falciparum asexual stage
infection (diagnosed by PCR)
75 (197/262)
P. falciparum gametocyte carriers 19 (52/275)
Subjects with Schistosoma haematobium infection 75 (214/284)
Subjects with filarial infection* 28 (81/287)
Helminth infection status
Subjects with no helminth infection 20 (55/284)
Subjects infected with one helminth species 57 (163/284)
Subjects infected with more than one
helminth species
23 (66/284)
Subjects with P. falciparum and helminth coinfection 55 (155/284)
F = female; IQR = interquartile range; M = male; PCR = polymerase chain reaction.
*Loa loa and Mansonella perstans.
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subjects (Table 2). Also when malarial parasites were detected
by PCR, we observed a higher malarial prevalence in
S. haematobium–infected individuals, albeit not statistically
significant (P = 0.07; Table 2). We did not detect any differ-
ences when comparing those with and without filarial infec-
tions (Table 2). The absence of association between filaria
and carriage of sexual and asexual forms of P. falciparum
remained even after correction for age in a multivariable
analysis (data not shown).
In this study, we measured the total IgG response of the
participants to three asexual (MSP1, AMA1, and GLURP)
and two sexual (Pfs48/45 and Pfs230) P. falciparum antigens.
We did not observe a statistically significant effect of age or
gender on the level of the different antibodies (data not
shown). Asexual P. falciparum parasites, as determined by
microscopy, did not influence the level of the five antibodies
measured. However, when P. falciparum asexual form was
determined by PCR, higher antibody concentrations were
observed in infected subjects compared with uninfected for
Pfs230 (65.7 [95% confidence interval {CI}: 59.3–72.5] versus
51.1 [95% CI: 42.7–60], P = 0.01) and AMA1 (1430.8 [95%
CI: 1064.3–1904.9] versus 689.9 [95% CI: 391.7–1147.3], P =
0.01) but not for other antibodies, as shown in Table 3.
Moreover, we found that carriage of P. falciparum gameto-
cytes was associated with a trend toward increased antibodies
to Pfs48/45 in gametocyte-positive (55.1 [95% CI: 46.2–66.2]
compared with gametocyte-negative individuals (44.7 [95%
CI: 40.4–49.3], P = 0.056). The same trend was observed for
Pfs230 (72 [95% CI: 60.5–84.4] in gametocyte-positive and
59.8 [95% CI: 54.1–65.6] in gametocyte-negative individuals,
P = 0.068) as shown in Table 3.
Regarding helminth infections, we observed a significant
decrease of Pfs48/45 IgG titers in S. haematobium–infected
subjects compared with those uninfected (44.2 [95% CI: 39.7–
49.2] versus 53.2 [95% CI: 46.3–60.7], P = 0.037), whereas
no difference was seen for Pfs230 antibody titers, nor for
the other antibodies as shown in Table 3. In contrast to
S. haematobium, filarial infection was not associated with a
significant effect on the concentration of antibodies to sexual
or asexual P. falciparum stage antigens.
To further assess how schistosome infection affects the
humoral responses to P. falciparum sexual and asexual stage
antigens, we performed a multivariable analysis on the titer of
antibodies against the five antigens. In this analysis, asexual
P. falciparum infection diagnosed by PCR, P. falciparum
gametocyte carriage, hemoglobin concentration, and participant
age was used as predictor variables. These predictor variables
were selected based on their reported effect on gametocyte
carriage and on antibodies specific to P. falciparum asexual or
sexual stage antigens. We fitted the model for the total popu-
lation as well as for S. haematobium–uninfected and –infected
individuals, separately. In the total population, we observed
no apparent association between Pfs230, AMA1, GLURP,
or MSP1 antibody responses and S. haematobium infection
(Table 4), but we did find a significant decrease of Pfs48/45
antibody titer in Schistosoma-infected subjects compared with
their uninfected counterparts (β = 0.68, 95% CI: 0.48–0.97,
P = 0.035; Table 4). When restricting the analysis to subjects
TABLE 2
Characteristics of the study population stratified by helminth infections
Schistosoma haematobium infection status
P
Filarial infection status*
PUninfected subjects Infected subjects Uninfected subjects Infected subjects
Age in years: median (IQR) 10 (6) 11 (6.7) 0.9 10 (5) 14 (8) < 0.001
Sex (M/F) 38/32 112/102 0.2 113/93 40/41 0.4
Hemoglobin level (g/dL), mean (SD) 11.6 (1.3) 11.2 (1.45) 0.06 11.3 (1.3) 11.5 (1.6) 0.3
Subjects with Plasmodium falciparum asexual stage
infection (diagnosed by microscopy), n (%)
18/70 (26%) 100/214 (47%) 0.003 42% (86/206) 43% (34/81) 1
Subjects with P. falciparum asexual stage infection
(diagnosed by PCR), n (%)
45 (66.2%) 146 (78%) 0.07 136 (74%) 58 (78%) 0.55
P. falciparum gametocyte carriers, n (%) 14 (20.1%) 36 (18%) 0.8 41 (21%) 11 (14%) 0.2
F = female; IQR = interquartile range; M = male; PCR = polymerase chain reaction; SD, standard deviation.
*Loa loa and Mansonella perstans.
TABLE 3
Effect of malarial and helminth infection as well as malarial exposure on the level of total IgG specific to Pfs48/45, Pfs230, GLURP, MSP1,
and AMA1
Pfs48/45,
mean (±SD) P
Pfs230,
mean (±SD) P
GLURP,
mean (±SD) P
MSP1,
mean (±SD) P
AMA1,
mean (±SD) P
Plasmodium falciparum asexual
stage infection status
(diagnosed by microscopy)
Uninfected 46 (6.3) 0.8 59.5 (14.3) 0.3 55.9 (5.9) 0.25 54.8 (6.7) 0.09 1064.7 (12.5) 0.14
Infected 47 (6.5) 65.1 (15.6) 71.7 (5.9) 36.9 (7.2) 1533.8 (17.9)
P. falciparum asexual stage
infection status
(diagnosed by PCR)
Uninfected 40.2 (5.5) 0.068 51.1 (11.5) 0.01 48.6 (5.7) 0.16 53 (7) 0.38 689.9 (10) 0.01
Infected 48.7 (6.6) 65.7 (16.2) 69.2 (6) 41.3 (7) 1430.8 (17)
P. falciparum gametocyte
carriage status
Non carriers 44.7 (6.4) 0.056 59.8 (15.1) 0.068 58.2 (6) 0.36 47.6 (6.8) 0.64 1226 (16.4) 0.6
carriers 55.1 (5.7) 72 (13) 74 (5) 41.2 (7.7) 1439 (10.5)
Schistosoma haematobium
infection status
Uninfected 53.2 (4.3) 0.037 63.3 (12.3) 0.7 69 (4.7) 0.53 55.3 (5.2) 0.33 1372.2 (11.4) 0.6
Infected 44.2 (7) 61.3 (15.7) 60 (6.4) 43.7 (7.3) 1205.8 (16.2)
Filarial infection status* Uninfected 46.5 (6.4) 0.9 62.2 (15.4) 0.8 61 (5.4) 0.79 47.8 (7) 0.68 1169.1 (15.9) 0.4
Infected 46.2 (6.2) 60.9 (13.5) 65 (7.5) 43.1 (7) 1455.3 (12.4)
IgG = immunoglobulin G; PCR = polymerase chain reaction; SD, standard deviation; GLURP = glutamate rich protein; AMA1 = apical membrane antigen 1; MSP1 = merozoite surface protein 1.
*Loa loa andMansonella perstans.
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not infectedwith S. haematobium, we observed thatP. falciparum
infection as determined by PCR was associated with a signifi-
cant increase of Pfs48/45 (β = 1.84, 95%CI: 1.2–2.7, P = 0.003;
Table 4) and Pfs230 specific antibodies (β = 1.9, 95% CI: 1.2–
3.3, P = 0.02) as shown in Table 4. This association was
not seen when the model was applied to those infected with
S. haematobium (Table 4).
DISCUSSION
To our knowledge, this is the first study to assess the effect
of helminth infections on both the carriage and the humoral
immune response to P. falciparum sexual stage antigens. Our
primary interest was to determine if gametocyte production,
and antibody responses to gametocyte antigens, was higher
in malaria-schistosome coinfected subjects. What we observed
is that while gametocyte carriage as determined by micros-
copy did not differ between individuals infected with malaria
alone and with malaria and S. haematobium, antibody levels
to Pfs48/45 sexual stage antigen but not to Pfs230 were lower
in coinfected individuals. Our initial hypothesis, based on
the literature, was that a higher prevalence of P. falciparum
gametocytes and markers of gametocyte exposure would be
found in S. haematobium coinfected individuals.22,23 Con-
trary to this hypothesis, we observed no apparent effect of
S. haematobium coinfection on gametocyte carriage. This
could be explained by the fact that we used microscopy to
detect gametocytes, which is less sensitive than molecular
methods.36 It is possible that molecular detection methods
for gametocytes or functional assays (e.g., standard membrane
feeding) could have given a different picture in line with what
has been described in two studies in the literature showing
that helminth infections increase gametocyte carriage.22,23 A
more sensitive marker of gametocyte exposure than micros-
copy might be antibodies to two gametocyte antigens, Pfs230
and Pfs48/45.37,38 Antibody responses to these molecules
indeed appeared to be elevated in patent gametocyte carriers,
suggesting that they may serve as specific markers of gameto-
cyte exposure. Interestingly, in the current study, lower levels
of antibodies to Pfs48/45 but not to Pfs230 were seen in sub-
jects with schistosome infection. This suggests either a spuri-
ous finding, a selective suppressory effect of Schistosoma
coinfection on antibody responses against Pfs48/45 or lower
immunogenicity of Pfs48/45 and amenable to modulation. In
line with our finding, a study in Papua New Guinea with high
transmission of malaria showed that if sera recognized the
gametocyte surface antigens, the response was dominated by
antibodies to Pfs230 with fewer people showing a response to
pfs48/45.39 However, helminth infections, which are highly
prevalent in the area were not considered and therefore it is
not possible to delineate whether the low response to Pfs48/45
is due to the presence of helminth infections.
In our study, we noted that a higher percentage of
Schistosoma-infected participants was infected with P. falciparum,
and this was statistically significant when parasites were
detected by microscopy but fell short of significance when
PCR was used to detect malarial parasites. One way to inter-
pret this is that schistosome infections are associated with
higher burden of malarial parasites. The higher carriage of
P. falciparum suggests a possible interaction between hel-
minths and P. falciparum, which is unlikely to be explained by
structural features of the houses, an important factor in
TABLE 4
Multivariable linear regression analysis assessing the effect of Schistosoma haematobium infection, Plasmodium falciparum infection as detected
by PCR, hemoglobin level as well as age on antibodies to P. falciparum sexual and asexual stage antigens
Antibody Covariates
S. haematobium infection status
All subjects S. haematobium–uninfected subjects S. haematobium–infected subjects
β (95% CI) P value β (95% CI) P value β (95% CI) P value
Pfs48/45 S. haematobium infection 0.68 (0.48–0.97) 0.0352 – – – –
Infection with asexual forms of P. falciparum 1.14 (0.78–1.67) 0.487 1.85 (1.25–2.74) 0.003 0.93 (0.56–1.55) 0.773
Carriage of sexual forms of P. falciparum 1.41 (0.93–2.15) 0.106 1.16 (0.73–1.85) 0.529 1.5 (0.87–2.6) 0.142
Hemoglobin level 1 (0.89–1.13) 0.95 1.02 (0.89–1.18) 0.748 1.01 (0.87–1.17) 0.946
Age 1.01 (0.99–1.03) 0.125 1.02 (1–1.03) 0.03 1.01 (0.99–1.04) 0.316
Pfs230 S. haematobium infection 0.79 (0.54–1.17) 0.237 – – – –
Infection with asexual forms of P. falciparum 1.19 (0.78–1.81) 0.412 1.91 (1.1–3.34) 0.023 0.93 (0.54–1.61) 0.792
Carriage of sexual forms of P. falciparum 1.30 (0.82–2.07) 0.264 1.37 (0.71–2.66) 0.348 1.26 (0.7–2.27) 0.431
Hemoglobin level 0.98 (0.86–1.12) 0.785 0.97 (0.79–1.19) 0.757 0.98 (0.84–1.16) 0.86
Age 1.01 (0.99–1.03) 0.261 1.01 (0.99–1.03) 0.345 1.01 (0.99–1.04) 0.293
AMA1 S. haematobium infection 0.64 (0.3–1.35) 0.242 – – – –
Infection with asexual forms of P. falciparum 2.02 (0.9–4.53) 0.085 3.74 (1.08–12.93) 0.038 1.56 (0.55–4.38) 0.4
Carriage of sexual forms of P. falciparum 1.25 (0.51–3.05) 0.629 1.41 (0.32–6.17) 0.645 1.16 (0.38–3.52) 0.786
Hemoglobin level 1.03 (0.8–1.32) 0.846 1.24 (0.79–1.95) 0.344 0.97 (0.72–1.32) 0.86
Age 1.03 (0.99–1.07) 0.085 1.03 (0.98–1.08) 0.258 1.04 (0.99–1.09) 0.144
MSP1 S. haematobium infection 0.76 (0.43–1.36) 0.357 – – – –
Infection with asexual forms of P. falciparum 0.69 (0.37–1.29) 0.248 0.79 (0.3–2.1) 0.633 0.66 (0.3–1.47) 0.312
Carriage of sexual forms of P. falciparum 0.92 (0.46–1.85) 0.822 0.61 (0.19–1.96) 0.4 1.06 (0.45–2.48) 0.9
Hemoglobin level 0.91 (0.75–0.11) 0.363 0.99 (0.69–1.41) 0.95 0.89 (0.71–1.13) 0.341
Age 1.01 (0.98–1.04) 0.492 0.998 (0.96–1.04) 0.928 1.02 (0.98–1.06) 0.4
GLURP S. haematobium infection 0.81 (0.45–1.32) 0.399 – – – –
Infection with asexual forms of P. falciparum 1.52 (0.9–2.56) 0.116 2.17 (0.9–5.21) 0.082 1.34 (0.69–2.56) 0.386
Carriage of sexual forms of P. falciparum 1.36 (0.76–2.42) 0.303 1.37 (0.48–3.89) 0.551 1.33 (0.66–2.68) 0.427
Hemoglobin level 0.99 (0.84–1.16) 0.878 1.19 (0.87–1.64) 0.276 0.94 (0.77–1.14) 0.522
Age 1.03 (1–1.05) 0.027 1.02 (0.99–1.06) 0.186 1.03 (0.99–1.06) 0.068
Three models were considered for this analysis. In the first model, all subjects were included regardless of whether or not they were infected with S. haematobium. Subsequent analysis focus
on S. haematobium–uninfected (model 2) or –infected subjects (model 3). CI = confidence interval; PCR = polymerase chain reaction.
397HELMINTH INFECTIONS, P. FALCIPARUM, AND ANTIBODY RESPONSES
malarial transmission, as houses in our study area were very
similar to each other. Other factors such as nutritional status
or proximity to water bodies could explain such an interac-
tion but we did not collect data on these parameters.
We did not observe an effect of schistosomiasis on the anti-
body titers to P. falciparum asexual stage antigens, AMA1,
GLURP, or MSP1. This is in line with the results from Lyke
and others7 in Mali but it contrasts to the observations of
Diallo and others8 in Senegal who reported a significant
increase of the humoral response to Plasmodium antigens in
Schistosoma-infected subjects. A plausible explanation of these
differences might lie in the characteristics of the populations
studied as well as in the epidemiological feature of malaria
and schistosomiasis in the different study areas. For instance,
in the study in Mali, all participants came from an area
where, like in our study area, both malaria and schistosomia-
sis show intense seasonal transmission.7 In contrast, the study
in Senegal was conducted in an area of low malarial trans-
mission and helminth-free subjects were recruited from a vil-
lage, where S. haematobium had never been reported before
and was absent at the time of the study.8 Because exposure
to these parasites is expected to be very different in the two
studies, this could affect the immune response profiles mea-
sured. Finally, it is also important to emphasize that Diallo and
others measured the level of the different IgG subclasses,
whereas Lyke and others and ourselves studied total IgG.
Future studies should examine the effect of helminths on IgG
subclasses since protection to malaria is linked with an
increase of cytophilic antibodies of IgG1 and IgG3 subclasses.
Why filarial infections did not affect the antibody responses to
malarial antigens is not clear. Species-dependent effect of
helminth on malariometric indices and on malaria-specific
immune response has already been reported.40,41 It is possible
that schistosomiasis has a more pronounced effect on the host
immune response and/or metabolism than filarial infections. In
this study, we observed, for example, that Schistosoma but not
filaria-infected subjects were more likely to be anemic. Future
studies will need to expand and further assess the effect of
filaria or other helminths species on malarial transmission.
The present study should be regarded as hypothesis gener-
ating and calls for additional work to assess the association
between helminths and malarial transmission. Future studies
should ideally have a longitudinal design and include the col-
lection of material for sensitive gametocyte detection by RNA-
based methods.42 These studies will equally need to take
into consideration the possible confounding effect of other
helminths infection such as intestinal nematodes. Future studies
should also determine the functional importance of the observed
decrease of Pfs48/45 specific IgG in Schistosoma-infected sub-
jects using mosquito-feeding assays.
In summary, this study suggests a selective effect of
S. haematobium on the humoral response to an important
P. falciparum sexual stage antigen. It indicates an association
between helminths and malarial transmission and may form a
starting point for more detailed studies on the consequences
of dual infections for disease transmission.
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